HVC
ATRS

Healthcare Value Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Healthcare Value Capital’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-200,000
Closed -$669K – 22
2019
Q3 		$669K Hold
200,000
– – 1.21% 19
2019
Q2 		$658K Buy
+200,000
New +$579K 1.23% 17
2018
Q3 		– Sell
-100,000
Closed -$258K – 14
2018
Q2 		$258K Buy
+100,000
New +$249K 0.73% 11

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Healthcare Value Capital's ATRS Position: Q3 2021 in Review

Healthcare Value Capital held its Antares Pharma, Inc. (ATRS) position steady in Q3 2021 at 500,000 shares worth $1.82M. The position accounts for 3.59% of the portfolio, ranked #15.

Healthcare Value Capital first reported a position in ATRS in Q2 2018 and has held it in 13 quarters since. The position peaked at $2.18M in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Healthcare Value Capital held 500,000 shares of Antares Pharma, Inc. worth $1.82M as of Q3 2021.
  • Healthcare Value Capital left its Antares Pharma, Inc. share count unchanged in Q3 2021.
  • Antares Pharma, Inc. made up 3.59% of Healthcare Value Capital's portfolio in Q3 2021, its #15 holding.
  • Healthcare Value Capital first reported a position in Antares Pharma, Inc. in Q2 2018 and has held it in 13 quarters since.
  • Healthcare Value Capital's Antares Pharma, Inc. position peaked at $2.18M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.